This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuste, J.
Right arrow Articles by Aguilar, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuste, J.
Right arrow Articles by Aguilar, L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2002, p. 4043-4044, Vol. 46, No. 12
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.12.4043-4044.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Combined Effect of Specific Antibodies (as Serotherapy or Preimmunization) and Amoxicillin Doses in Treatment of Streptococcus pneumoniae Sepsis in a Mouse Model


arrow
LETTER
 
Efficacy of amoxicillin concentrations in serum lower than the MIC for the infecting serotype 6B penicillin-resistant Streptococcus pneumoniae strain was demonstrated in animals that had received passive specific immunization prior to infection (1) and was linked to faster clearance of the bacteremia (2). This study measured these effects when the antibiotic and specific hyperimmune serum (HS) were simultaneously administered after infection with the same strain (amoxicillin MIC and minimum bactericidal concentration = 4 and 4 µg/ml).

HS was obtained by immunizing 8- to 12-week-old female BALB/c mice with the heat-inactivated strain as previously described (1). Sixty animals were intraperitoneally (i.p.) infected with the pneumococcal challenge dose (3.99 x 107 CFU/ml) as previously described (1) and monitored for 18 days. The distribution of animals was as follows: (i) untreated controls (10 animals) received i.p. 200 µl of nonimmune mouse serum diluted to one-quarter in phosphate-buffered saline (normal serum [NS]) as a placebo; (ii) HS groups of 10 animals received HS diluted to one-quarter in phosphate-buffered saline, with i.p. administration of 200 µl of HS prior to infection in 5 animals and 1 h after infection in 5 animals; (iii) antibiotic-treated groups of 10 animals received amoxicillin at 3.12 mg/kg of body weight plus NS, and 10 animals received amoxicillin at 25 mg/kg of body weight plus NS (in both cases, 100 µl of the antibiotic and 200 µl of NS [as a single i.p. injection given simultaneously with the first antibiotic dose] were administered i.p.); (iv) combined groups of 20 animals received i.p. 100 µl of amoxicillin (3.12 mg/kg for 10 animals and 25 mg/kg for 10 animals) plus 200 µl of HS. Of these, five animals in each group received HS prior to infection and five animals received HS 1 h after infection. Antibiotic treatment was administered three times a day for 48 h, starting 1 h after infection. Deaths were recorded over 18 days. Blood samples were obtained as previously described (2, 3) over the 18-day follow-up period.

Survival curves were obtained by the Kaplan-Meier method. A Cox regression analysis was used to compare survival rates in groups receiving HS pre- and postinfection. The Kruskal-Wallis test was used to detect differences in peak colony counts in blood between animals treated with 25 mg of amoxicillin per kg that received HS and those that did not receive it.

Mortality was 100% in untreated animals (within 48 h) and in those treated with amoxicillin at 3.12 mg/kg alone (60% within 48 h, 90% at day 4, and 100% at day 10). All animals treated with amoxicillin at 25 mg/kg (with or without HS) survived. Survival rates in the study group given HS and that given amoxicillin at 3.12 mg/kg plus HS are shown in Fig. 1. Survival of animals receiving HS prior to infection was significantly (P < 0.008) higher than that of animals receiving HS postinfection, with a 2.5 times higher probability of death in the latter group (Cox regression coefficient, -2.569). Significantly (P = 0.006) lower median peak colony counts (6.12 x 102 CFU/ml) were found in animals treated with amoxicillin at 25 mg/kg plus HS than in those treated with 25 mg of amoxicillin per kg alone (3.52 x 104 CFU/ml) (Fig. 2). Differences between the 25-mg/kg amoxicillin treatment groups can only be highlighted by colony counts. Since the increase in the maximum colony counts in blood was related to an increase in the probability of death in a previous study (3), the ability of the treatment to reduce maximum colony counts in blood seems an important therapeutic endpoint.



View larger version (16K):
[in this window]
[in a new window]
  		FIG. 1. Survival curves over the 18-day follow-up period for animals receiving HS prior to infection (•), HS after infection ({blacksquare}), amoxicillin at 3.12 mg/kg plus HS prior to infection ({blacktriangleup}), and amoxicillin at 3.12 mg/kg plus HS after infection.



View larger version (17K):
[in this window]
[in a new window]
  		FIG. 2. Mean bacteremic profile, over 432 h, of untreated animals ({circ}) and mice treated with amoxicillin at 25 mg/kg ({blacksquare}), with amoxicillin at 25 mg/kg plus HS administered prior to infection ({blacktriangleup}), or with amoxicillin at 25 mg/kg plus HS administered after infection with the challenge dose (•).

Bearing in mind the resistant profile of the infecting strain, these findings suggest that strategies of immunization rather than serotherapy are effective in gaining antibiotic efficacy against resistant pneumococci.


arrow
ACKNOWLEDGMENTS
 
We express our gratitude to A. Pedromingo for performing the statistical analysis.


arrow
REFERENCES
 
    1
  1. Casal, J., L. Aguilar, I. Jado, J. Yuste, M. J. Giménez, J. Prieto, and A. Fenoll. 2002. Effects of specific antibodies against Streptococcus pneumoniae on pharmacodynamic parameters of ß-lactams in a mouse sepsis model. Antimicrob. Agents Chemother. 46:1340-1344.[Abstract/Free Full Text]
    2. 2
  2. Yuste, J., M. J. Giménez, I. Jado, A. Fenoll, L. Aguilar, and J. Casal. 2001. Enhanced decrease of blood colony counts by specific anti-pneumococcal antibodies in the presence of sub-inhibitory concentrations of amoxicillin. J. Antimicrob. Chemother. 48:594-595.[Free Full Text]
    3. 3
  3. Yuste, J., I. Jado, M. J. Giménez, L. Aguilar, F. Molero, A. Fenoll, and J. Casal. 2002. Modification of bacteraemia by specific antibodies and relation with mortality in a pneumococcal mouse sepsis model. Clin. Exp. Immunol 128:411-415.[Medline]
J. Yuste
A. Fenoll
J. Casal*
Centro Nacional de Microbiología
Instituto de Salud Carlos III
Ctra. Majadahonda-Pozuelo Km. 2
28220 Majadahonda
Madrid, Spain

M. J. Giménez
L. Aguilar
Medical Department
GlaxoSmithKline
Tres Cantos
Madrid, Spain

* Phone: 34 91 5097975
Fax: 34 91 5097966
E-mail: jcasal{at}isciii.es.

Antimicrobial Agents and Chemotherapy, December 2002, p. 4043-4044, Vol. 46, No. 12
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.12.4043-4044.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Brandt, C. T., Frimodt-Moller, N., Lundgren, J. D., Pedersen, M., Skovsted, I. C., Rowland, I. J., Ostergaard, C. (2006). Evaluation of anti-pneumococcal capsular antibodies as adjunctive therapy in experimental pneumococcal meningitis. J Antimicrob Chemother 58: 1291-1294 [Abstract] [Full Text]  
  • Tarrago, D., Aguilar, L., Gimenez, M. J., Fenoll, A., Casal, J. (2004). Effects of Amoxicillin Subinhibitory Concentrations on the Cross-Protection Developed by Pneumococcal Antibodies in Mouse Sepsis Caused by an Amoxicillin-Resistant Serotype 6B Streptococcus pneumoniae Strain. Antimicrob. Agents Chemother. 48: 4144-4147 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yuste, J.
Right arrow Articles by Aguilar, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yuste, J.
Right arrow Articles by Aguilar, L.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»